We are proud to announce that CEM has recently become a clinical investigation site for a National Institute of Health trial sponsored by Duke University. The purpose of the study is to investigate the efficacy and safety of EDTA chelation for treatment of heart disease!
We are looking for subjects to enroll in this important study and would like to enlist your help. Participants do not need to be patients of the clinic but do need to be over the age of 50 and have had a heart attack in the past. There are some other criteria found on this section of this site. If you or anyone you know might be interested or potentially eligible, please speak to them. Help them connect with us either by providing our information, or if they approve, please provide us with their contact information.
Time is running out to recruit new participants so thank you for our help and we appreciate your trust and confidence in CEM!
Chris Hatlestad, MD
